Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue

Abstract

Get full access to this article

View all access options for this article.

References

John Arrowsmith . Trial watch: phase III and submission failures: 2007–2010. Nature Reviews Drug Discovery 2011; 10: 87–87.

Pober

Neuhauser

Pober

. Obstacles facing translational research in academic medical centers. FASEB J 2001; 15: 2303–13.

Collins FS. Reengineering translational science: the time is right. Sci Transl Med 2011;3(90). doi: 10.1126/scitranslmed.3002747.

FDA: Challenges and Opportunities Report – March 2004. http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm.

Pedro

Maria

. Uncertainty in the translation of pre-clinical experiments to clinical trial. Why do most phase III clinical trials fail. Curr Gene Ther 2009; 9: 368–74.

Seok

Warren

Cuenca

Mindrinos

Baker

Richards

McDonald-Smith

Gao

Hennessy

Finnerty

López

Honari

Moore

Minei

Cuschieri

Bankey

Johnson

Sperry

Nathens

Billiar

West

Jeschke

Klein

Gamelli

Gibran

Brownstein

Miller-Graziano

Calvano

Mason

Cobb

Rahme

Lowry

Maier

Moldawer

Herndon

Davis

Xiao

Tompkins

. Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110: 3507–12.

Huh

Leslie

Matthews

Fraser

Jurek

Hamilton

Thorneloe

McAlexander

Ingber

. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med 2012; 4: 159ra147–159ra147.

Huh

Matthews

Mammoto

Montoya-Zavala

Hsin

Ingber

. Reconstructing organ-level lung functions on a chip. Science 2010; 328: 1662–8.